The CDC’s Advisory Committee on Immunization Practices voted 12-0 Friday afternoon to recommend changes to who is eligible for COVID-19 shots.
The recommendation mirrors the authorization the US FDA gave to the Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX), and Novavax (NASDAQ:NVAX) shots in late August.
As adopted, the recommendation is for vaccinating for adults 65 years and older “based on individual-based decision-making.” For those six months to 64 years old, it is also based on the same decision-making “with an emphasis that the risk-benefit of vaccination is most favorable to individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk…”
During debate, it was clarified that getting a COVID shot can be done — as in the past — by pharmacists.
The vote is not binding and a final decision will be made by acting CDC director Jim O’Neill, who is also deputy secretary at HHS, making him close to HHS Secretary Robert F. Kennedy Jr.
Dear Readers: We recognize that politics often intersect with the financial news of the day, so we invite you to click here to join the separate political discussion.
